Any CJC-1295/Ipamorelin source should be evaluated with the same criteria used for other research peptides: Batch-specific Certificate of Analysis, not a generic sample PDF HPLC purity and mass spectrometry identity confirmation Clear distinction between CJC-1295 no-DAC, CJC-1295 DAC, and blends No therapeutic claims, dosing claims, or implied human-use instructions Research-use-only labeling and purchase certification If a vendor describes CJC-1295/Ipamorelin as "FDA approved," "pharmaceutical grade," or an approved anti-aging therapy, that is a red flag
Spravato, which the FDA approves for certain cases, is easier to get through the insurance process
& Larsson, C
Dosages can be adjusted to minimize side effects and maximize weight loss
While theyre currently FDA approved for Type 2 diabetes and weight loss, these medications are increasingly being used off-label in patients with Type 1 diabetes as well as those with both Type 1 and 2 disease or double diabetes. Because existing studies have largely focused on short-term metabolic outcomes, such as glucose control or weight loss, Dr
